These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 26941360)

  • 1. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan enhances the success of myoblast transplantation.
    Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
    Hindi SM; Shin J; Ogura Y; Li H; Kumar A
    PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/enhancer binding protein β is required for satellite cell self-renewal.
    Lala-Tabbert N; AlSudais H; Marchildon F; Fu D; Wiper-Bergeron N
    Skelet Muscle; 2016 Dec; 6(1):40. PubMed ID: 27923399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice.
    Benabdallah BF; Bouchentouf M; Rousseau J; Tremblay JP
    Cell Transplant; 2009; 18(7):709-18. PubMed ID: 19520047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of omega-3 on matrix metalloproteinase-9, myoblast transplantation and satellite cell activation in dystrophin-deficient muscle fibers.
    de Carvalho SC; Hindi SM; Kumar A; Marques MJ
    Cell Tissue Res; 2017 Sep; 369(3):591-602. PubMed ID: 28623422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.
    Zhang Y; Zhu Y; Li Y; Cao J; Zhang H; Chen M; Wang L; Zhang C
    Hum Mol Genet; 2015 Nov; 24(21):6029-40. PubMed ID: 26264578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia.
    Marchildon F; Fu D; Lala-Tabbert N; Wiper-Bergeron N
    Cell Death Dis; 2016 Feb; 7(2):e2109. PubMed ID: 26913600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells.
    Vallejo D; Hernández-Torres F; Lozano-Velasco E; Rodriguez-Outeiriño L; Carvajal A; Creus C; Franco D; Aránega AE
    Stem Cell Reports; 2018 Apr; 10(4):1398-1411. PubMed ID: 29641992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
    Nik-Ahd F; Bertoni C
    Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
    Fakhfakh R; Michaud A; Tremblay JP
    Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
    Luo L; Zhou HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin gel improves the survival of transplanted myoblasts.
    Gerard C; Forest MA; Beauregard G; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):127-37. PubMed ID: 21535909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β.
    Fu D; Lala-Tabbert N; Lee H; Wiper-Bergeron N
    J Biol Chem; 2015 Apr; 290(16):10200-7. PubMed ID: 25720496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
    Iyer PS; Mavoungou LO; Ronzoni F; Zemla J; Schmid-Siegert E; Antonini S; Neff LA; Dorchies OM; Jaconi M; Lekka M; Messina G; Mermod N
    Mol Ther; 2018 Apr; 26(4):1093-1108. PubMed ID: 29503200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.